HPV and male urinary system tumors: Progress in research.
- Author:
Shi-Yi XU
1
;
Jun YIN
2
;
Kun ZHANG
2
;
Hao-Li YIN
2
Author Information
1. Chemotherapy Center for Outpatients, Department of Emergency, Yunnan Cancer Hospital, Kunming, Yunnan 650118, China.
2. Department of Urology, Yunnan Cancer Hospital, Kunming, Yunnan 650118, China.
- Publication Type:English Abstract
- Keywords:
human papilloma virus;
genitourinary system tumor;
vaccine
- MeSH:
Humans;
Male;
Papillomavirus Infections/virology*;
Papillomaviridae;
Urologic Neoplasms/virology*
- From:
National Journal of Andrology
2025;31(3):252-257
- CountryChina
- Language:Chinese
-
Abstract:
Human papilloma virus (HPV), a cancer-causing DNA virus, is a most common sexually transmitted virus and one of the major public health problems worldwide currently. Although HPV infection is relatively common in men, routine HPV detection is still difficult to be applied in clinical practice due to the lack of standard HPV detection methods and the complexity of its detection. Recent studies have explored the relationship between HPV and genitourinary tumors, revealed different results because of geographic differences, histological subtypes and detection methods, and stressed the importance of clarifying the role of HPV in the development and progression of genitourinary tumors. This review focuses on the complicated relationship of HPV with male genitourinary tumors, reveals its main carcinogenic mechanisms, and presents a new insight into the impact of HPV on the genitourinary system.
